EquiReason

EquiReason research coverage

Credo Technology Group Holding Ltd CRDO

Technology · Semiconductors

23quarters analysed
12SEC filings read
2segments identified
13institutional managers tracked

Segments it reports

The business segments Credo Technology Group Holding Ltd reports in its own SEC filings.

  • Reportable Segment

Product lines it reports

The product and service lines Credo Technology Group Holding Ltd breaks its revenue into.

  • License
  • Product Engineering Services

Where its revenue is reported

The geographies Credo Technology Group Holding Ltd reports revenue for. How much comes from each is in the product.

  • United States
  • Hong Kong
  • RESTOFTHEWORLD
  • China
  • Taiwan

What we read

The sources behind this company, and how many records of each we hold.

  • Financial statements27
  • Quarterly metric series12
  • Business segments2
  • SEC filings12
  • Insider transactions (Form 4)6
  • Institutional positions (13F)7
  • Earnings events1
  • Earnings quality checks6
  • Estimate revisions11
  • GAAP vs non-GAAP reconciliation1
  • Seasonal pattern6
  • Multi-period trajectory7
  • Inflection detection1
  • Fiscal calendar1
  • Index membership4

What we look for

Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.

  • Guidance changes2
  • Revenue series23
  • Margin series12
  • Cash flow series22
  • Earnings series23
  • Per-share series1
  • Operating cash flow series22

This page says how much of Credo Technology Group Holding Ltd we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.

Open CRDO in EquiReason

This page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies

Credo Technology Group Holding Ltd (CRDO) — research coverage | EquiReason